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The effect of dialysate temperature on energy transfer during hemodi- suspected on clinical grounds, all patients underwent CR and intra-
arterial angiography. Renographic restenosis of a kidney was definedalysis (HD). J.N.M. Barendregt, J.P. Kooman, F.M. van der Sande,
J.H.G.A. Buurma, P. Hameleers, A.M.M. Kerkhofs, K.M.L. Leunissen. as an abnormal CR according to consensus criteria. Angiography was
considered as the “gold standard” for presence of restenosis, definedDept. Internal Medicine, Academic Hospital, Maastricht, The Nether-
lands. It is well known that the use of low temperature (T) dialysate can as $50% luminal diameter reduction. Of the 93 kidneys (70 patients)
with successfully treated RAS, CR prior to intervention was normalhave a positive impact on hemodynamic stability during HD. However,
little is known on the energy transfer (ET) from the extracorporeal in 33 kidneys (19 patients). Consequently, follow-up was only possible
for 60 kidneys (60/93 5 65%) in 51 patients (51/70 5 73%). In 16system to the patient in relation to variations in dialysate T (Tdial). In
this study, we assessed ET, body T (Tbody), and blood pressure (BP) kidneys (16 patients) angiography showed restenosis. The sensitivity
of CR in diagnosing kidneys with restenosis was 9/16 5 56% and theduring dialysis with normal Tdial (37.58C) and low Tdial (35.58C). Nine
patients (4 males, 5 females; mean age 68 6 10 years) were studied specificity was 15/44 5 34%. The sensitivity and specificity of CR in
diagnosing patients with a restenosed kidney was 9/16 5 56% andwith the patient as his/her own control. Bicarbonate was used as dialy-
sate buffer. Hemophane membranes were used. Dialysis contained 11/35 5 31%. In conclusion, for the detection of restenosis after success-
fully treated RAS, CR can be applied in only two-thirds of the kidneys.,100 CFU/mL. Ultrafiltration volume was comparable between the 2
treatment sessions. ET was assessed by continuous measurement of T In those kidneys in which CR can be used for this purpose, it has a
poor diagnostic accuracy. Therefore, CR is of little value in the follow-in the arterial (Tart) and venous side (Tven) of the extracorporeal system
(Fresenius BTMt) according to the formula: ET 5 (Tven 2 Tart) * blood up of successfully treated atherosclerotic RAS.
flow * treatment time * specific thermal capacity (3.64 kJ/kg*8C) *
blood density (1052 kg/m3). Results:
Single center experience of tacrolimus versus cyclosporine-neoral in
renal transplantation. M. Christiaans, J. van Hooff, E. van Duijnhoven.
Department of Internal Medicine, University Hospital Maastricht, TheResults: mean6SD Tdial 37.5 Tdial 35.5 p
Netherlands. Randomized multicentre trials have proven the superior-
D Syst BP mmHg 243 621 222 626 ,0.05 ity of tacrolimus (FK) above CyA-Sandimmune in the prevention of
D Dias BP mmHg 215 610 0 619 0.07 rejection. An improved formulation of cyclosporin (CyA-Neoral,
Tbody before HD (8C) 36.7 60.3 36.4 60.6 NS NEO) has proven to prevent rejections better than CyA-Sandimmune.
Tbody after HD (8C) 37.2 60.2 36.4 60.3 ,0.001 Therefore the question arises, if FK also has a reduced rejection rate
Tven after HD (8C) 36.7 60.1 35.0 60.2 ,0.001 compared to NEO. No randomized trials have been performed compar-
ET (kJ) 286 643 2286 674 ,0.001 ing both drugs. We report on our single center experience comparing
NEO with FK. Patients and Methods: Included were 128 consecutive
patients receiving a renal allograft from July 1995 the up till October
Conclusion: Tbody remained stable during Tdial 5 35.58C despite signifi- 1997 treated with either NEO (n 5 74, trough-level 150–200 ng/mL)
cant energy loss and increased during Tdial 5 37.58C despite netto ET or FK (n 5 54, trough-level 15–20 ng/mL post-operative, decreasing
from the patient to the extracorporeal system. The latter suggests that to ″10 ng/mL at month 6). Outcome parameter was any rejection-
HD itself leads to intrinsic heat generation in the patient. The removal treatment within the first 6 months after transplantation. Rejections
of this excess heat in combination with the cardiovascular response to were usually biopsy-proven. Patients were followed up till December
maintain Tbody may be responsible for the beneficial hemodynamic 1, 1997. Statistical analysis: Cox-regression with suspected risk-factors:
effects of low Tdial. FK/NEO, age and gender of recipient, age of donor, mismatch for
HLA-DR, transplant number, PRA, donortype, and additional im-
munosuppressives: Mycophenolate Mofetil (MMF) or Azathioprine
Limited value of repeated renography in diagnosing restenosis in ath- (AZA). Results: Fifty-one patients were treated for a rejection
erosclerotic renovascular disease. J.M.A. van Ampting, I.J.R. Mertens, (39.8%). Significant risk factors contributing towards rejection were
J.M.H. de Klerk, P.J.G. van de Ven, F.J.A. Beek, H.A. Koomans, J.J. the use of NEO instead of FK (Odds ratio: 4.2, p 5 0.0001), addition
Beutler. Depts. of Nephrology and Hypertension, Nuclear Medicine and of MMF (p 5 0.01) and mismatch for HLA-DR (Odds ratio 0 vs 1 5
Radiology, University Hospital Utrecht, The Netherlands. We studied 3.4, p 5 0.006). Rejection-free survival was 85% for FK and 40% for
the sensitivity and specificity of captopril renography (CR) in diagnos- NEO. 26% of the NEO and 7% of the FK patients were treated for
ing restenosis after recanalization therapy for kidneys with atheroscle- recurrent rejections. ATG was needed in 14% and 4% respectively.
rotic renal artery stenosis (RAS). Seventy patients (43 males, 27 fe- Conclusion: In this single center study tacrolimus is superior also to
males, mean age 64 years, SD 8, range 44–76) with angiographic RAS cyclosporin-Neoral in preventing acute rejection. Moreover tacrolimus
(luminal diameter reduction $50%) in 116 kidneys were investigated patients experience fewer steroid-resistant rejections and less re-rejec-
(bilateral RAS in 25 patients, unilateral RAS and contra-lateral oc- tion compared to Neoral patients.
cluded kidney in 21, unilateral stenosis in 21 and stenosis to a solitary
kidney in 3). Renal artery stenoses optically successful treated with
stent placement or PTA (luminal diameter reduction ,50%, n 5 93) Gender affects the susceptibility to renal damage induced by nitric
oxide synthase inhibition in rats. A.M.G. Verhagen, H.A. Koomans,were further evaluated. After six months, or sooner if restenosis was
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J.A. Joles. Dept. of Nephrology, University Hospital, Utrecht, The Neth- of 153 consecutive new dialysis patients with chronic renal failure.
They participated in a large multicenter study to investigate dialysiserlands. Renal disease generally progresses more rapidly in men than
in women. In rats, chronic nitric oxide synthase (NOS) inhibition leads outcome in the Dutch population. The most recent laboratory investi-
gations (0–4 weeks) before the start of dialysis are given. GFR wasto proteinuria, renal damage and hypertension. It has been shown that
female rats have more nitric oxide than male rats. Thus, hypothetically, calculated as the mean of creatinine and urea clearance. Assessment of
nutritional status was done 3 months after start of dialysis by Subjectivefemale rats will be more resistant to the deleterious effects of NOS
inhibition. Therefore we studied the effects of chronic NOS inhibition Global Assessment (SGA) and anthropometry. The latter was used
to calculate lean body mass (%LBM). Results are shown below.on systolic blood pressure (SBP) and urinary protein excretion (UpV)
in male and female Sprague-Dawley rats. Rats were given the arginine
analog Nv-nitro-l-arginine (L-NNA) dissolved in drinking water at
20 and 100 mg/l (n 5 6/dose). Data are presented after 6 weeks (100 HD PD
mg/l) and 24 weeks (con and 20 mg/l).
Number 81 72
Age year 64 (13) 49 (18)*
Pcreatinine lmol/L 700 (300) 738 (316)l-NNA (mg/l) con 20 100
Purea mmol/L 33.3 (12.7) 30.7 (12.6)
Albumin g/L 34 (13) 36 (11)SBP ? mm Hg 14667 183615* 199612*
SBP / mm Hg 15564 163613 20566* GFR mL/min/173m2 6.5 (3.0) 6.0 (2.3)
Kt/Vurea /week 1.4 (0.8) 1.2 (0.5)UpV ? mg/day 3964 138635* 73625*
UpV / mg/day 861 1267 131635* NPNA 0.96 (0.34) 0.87 (0.27)
BMI at 3 months 24 (4) N 557 24 (4) N 559* P , 0.05 l-NNA versus con
% LBM at 3 months 74 (9) N 557 76 (10) N 559
SGA % normal at 3 60 N 557 70 N 559
At the low dose of l-NNA both SBP and UpV were increased in male, All values, mean 6 sd. P , 0.001
but not in female rats. All rats at 20 mg l-NNA/l survived. At the
high dose of l-NNA all rats died within 15 weeks (male: 7–8 weeks
and female: 6–15 weeks) with severe hypertension and proteinuria. 88% of the patients did not meet the DOQI recommendation of
Kt/V $ 2.0 as starting point of dialysis. However 60% had an nPNAThus female rats are more resistant than males rats to the deleterious
effects of low dose NOS inhibition, probably because they have more $0.8 g/kg/day. At 3 months 59% of the patients was well nourished,
based on Body Mass Index (BMI), %LBM and SGA. Mean SGANO. However, this resistance, which may be provided by estrogens,
is limited, and is overwhelmed at high dose l-NNA. Besides the well- score was 5.6 for HD and 5.9 for PD patients on a 7-point scale
where 6 and 7 are considered normal. It can be concluded that aknown protection against cardiovascular disease, female gender may
also protect the kidney against risk factors that compromise the NO good nutritional status is present at the start of dialysis in the Dutch
population, despite the relatively low values for Kt/V. This suggestssystem.
that Kt/V by residual renal function is not similar to Kt/V by dialysis
treatment. Therefore the two cannot simply be added up to assess
adequacy of dialysis.Risk factors for disease relapse in Wegener’s granulomatosis: influence
of Fcg receptor polymorphisms. H.M. Dijstelbloem, R.H.M. Scheepers,
W.W. Ooost, C.A. Stegeman, W.L. van der Pol, W.J. Sluiter, C.G.M.
Kallenberg, J.G.J. van de Winkel, J.W. Cohen Tervaert. Dept. of Internal Tetramerization of AQP2-E258K with wild-type AQP2 explains domi-
nant nephrogenic diabetes insipidus. E.J. Kamsteeg, T.A.M. Worm-Medicine, University Hospital Groningen, and Dept. of Immunology,
University Hospital Utrecht, The Netherlands. Several studies have re- houdt, C.H. van Os, P.M.T. Deen. Dept. of Cell Physiology, Univ. of
Nijmegen, The Netherlands. Autosomal Nephrogenic Diabetes Insip-cently identified Fcg receptor (FcgR) polymorphisms as genetic factors
influencing susceptibility to various autoimmune and infectious dis- idus (NDI) is caused by mutations in the vasopressin-dependent water
channel of the renal collecting duct, Aquaporin-2 (AQP2). A pre-eases. This genetic predisposition could also influence the expression
of Wegener’s granulomatosis (WG), an ANCA associated vasculitis viously described mutation in AQP2, E258K, causes a dominant inheri-
tance of NDI. Expressed in Xenopus oocytes, AQP2-E258K was shownwith chronic nasal carriage of Staphylococcus aureus (S. aureus) as an
important risk factor for disease relapses. We therefore analyzed three to be piled up in the Golgi apparatus, whereas AQP2 mutants in
recessive NDI were retarded in the endoplasmic reticulum. Sincefunctional FcgR polymorphisms in patients with WG for a possible
relation with disease expression and occurrence of relapses. Genomic AQP1 occurs in the plasma membrane as tetramers, we postulated that
tetramerization of AQP2-E258K with wild-type (wt) AQP2 impairsDNA was isolated from 91 Caucasian patients with histologically
proven WG and 154 Caucasian controls. Of particular interest in the proper routing of wt-AQP2 and causes dominant NDI. To test this
hypothesis, the effect of AQP2-E258K on wt-AQP2 function was stud-analysis were two allotypic forms of FcgRIIa (arginine (R) or histidine
(H) at amino acid position 131), and two allotypic forms of FcgRIIIa ied in oocytes and the oligomerization state of AQP2 in rat and human
kidney, and oocytes expressing AQP2 was determined. The water(valine (V) or phenylalanine (F) at amino acid position 158), all func-
tionally different. Linkage analysis demonstrated that patients with permeabilities (Pf in mm/sec 6 SEM) of oocytes injected with 0.3 ng
wt-AQP2 cRNA alone or in combination with 0.3 ng AQP2-R187CWG were more likely to relapse in the first five years after diagnosis
when homozygous R for FcgRIIa in combination with homozygous F cRNA (a mutant in recessive NDI) were not different (60 6 7 and
52 6 13, resp.). However, the Pf of oocytes co-injected with 0.3 ngfor FcgRIIIa (relative risk 3.3, CI 1.6 to 6.8). These polymorphisms
are associated both with decreased Fc receptor mediated clearance, wt-AQP2 and 0.3 ng AQP2-E258K cRNA (20 6 3) was significantly
reduced compared to wt-AQP2 alone and was similar to the Pf of non-possibly relevant in the context of chronic nasal carriage of S. aureus
injected oocytes (13 6 2). To determine the in vivo oligomerizationin patients. We conclude that the R-H polymorphism of FcgRIIa and
state of AQP2, membranes from rat and human renal medulla werethe V-F polymorphism of FcgRIIIa represent heritable risk factors for
solubilized in deoxycholate and fractionated on a 5–17.5% linear su-the development of disease relapses in WG.
crose gradient. Immunoblotting of gradient fractions and comparison
of peak fractions of AQP2 with those of co-fractionated marker pro-
teins revealed that rat and human AQP2 sedimented as a 120–140Residual renal function and nutritional status at the start of chronic
dialysis treatment. M.A.M. Jansen, J.C. Korevaar, F.W. Dekker, E.W. kDa complex. Since AQP1 peaked in identical fractions, AQP2 appar-
ently also forms homotetramers. Analyses of the oligomerization stateBoeschoten, R.T. Krediet, and the NECOSAD Study Group. Academic
Medical Center, Amsterdam, The Netherlands. Early start of dialysis of wt-AQP2 and AQP2-E258K expressed in oocytes also revealed
120–140 kDa complexes, whereas AQP2-R187C sedimented as ahas been hypothesised to prevent deterioration of nutritional status
and to lead to better clinical outcome. Objective of the present study smaller complex. Our results show that in vivo and in oocytes, wt-
AQP2 occurs in atetrameric form. Since AQP2-E258K, but not AQP2-was to analyse residual renal function and nutritional status in a cohort
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R187C, is able to form homotetramers, oligomerization of AQP2- tions. However, these CMV infections led more often to CMV disease
in patients treated with MMF than in those without MMF.E258K with wt-AQP2 and the subsequent impaired routing of the
hetero-tetramers likely explains dominant NDI in this particular family.
Strontium (Sr) accumulation in dialysis patients. An epidemiological
survey. I. Schrooten, M.M. Elseviers, L.V. Lamberts, M.E. De Broe,High sodium intake reveals phenotype differences in ACE I/D poly-
P.C. D’Haese. Dept. of Nephrology, University of Antwerp, Belgium.morphism. F.G.H. van der Kleij, P.E. de Jong, R.H. Henning, D. de
We previously reported on increased bone Sr levels in dialysis patientsZeeuw, G.J. Navis. Department of Internal Medicine, Division of Ne-
with osteomalacia (OM) vs those presenting other types of renal osteo-phrology, Department of Clinical Pharmacology, State University Gron-
dystrophy. A causal role of Sr in the development of OM was estab-ingen, The Netherlands. ACE DD genotype is associated with an in-
lished in a chronic renal failure rat model. To further elucidate thecreased rate of renal function loss, hypothesized to be due to increased
latter issue and to find out whether dialysis patients from particularangiotensin II (angII) generation. Data on the responses to angI, how-
centres/countries were at an increased risk for Sr accumulation a world-ever, are conflicting. We reported a blunted response of blood pressure
wide multicentre study was performed. In total 724 patients from 36and proteinuria to ACE-inhibition in DD genotype during high, but
dialysis centres of 20 countries were included. In each of the patientsnot low sodium intake in renal patients, suggesting sodium status affects
a serum sample was taken for Sr determination as were water andphenotype in ACE I/D polymorphism. We therefore studied the effects
dialysate samples taken at the various steps of the water purificationof angI and angII infusion (4 & 8 ng/kg/min, both doses one hour) on
process. For each patient clinical data and for each centre dialysisblood pressure and renal hemodynamics in healthy subjects in balance
modalities were registered. Strontium levels in serum of dialysis pa-on a 50 mmol Na1 as well as a 200 mmol Na1 intake. Baseline MAP
tients showed strong differences between the various centres, rangingand renal hemodynamics were similar for the genotype groups on
from mean 6 SD values of 29 6 11 mg/L to 466 6 90 mg/L (mean 6both Na1 intakes. The % change from pre-infusion value during angI
SD: 14 6 7 mg/L in normal subjects). It is of interest that the high Srinfusion are given:
levels were mainly found in less developed countries. Further on our
data point towards a role of the dialysis fluid in the accumulation of
the element as indicated by the strong correlation (r 5 0.75, p ,
MAP RVR (MAP/ERPF) 0.0001) between serum and dialysate Sr levels. Great centre-to-centre
variations were seen in the Sr content of the tap water which in generalNa1 50 200 50 200
could adequately be purified during the subsequent treatment. In one
DD, n 510 13 (9; 16) 21 (15; 27)# 74 (52; 81) 100 (84; 123)# third of the centres however, contamination of the final dialysis fluid
ID, n 510 11 (5; 16) 13 (7; 19) 59 (50; 66) 73 (69; 101) occurred by the addition of concentrates contaminated with Sr. Other
II, n 57 12 (8; 16) 12 (4; 20) 60 (50; 71) 63 (45; 78) factors such as duration of dialysis, vitamin D supplements and type
of phosphate binder seemed to play only a marginal role in the accumu-Data for 8 ng/kg/min: means and 95% confidence intervals
#: p , 0.05; DD vs. ID/II lation of the element. Data of this multicentre study indicate patients of
particular dialysis centres to be at an increased risk for Sr accumulation.
They underscore the possible role of the element in the development
The response of MAP and RVR to angI were significantly more pro- of OM within the current dialysis population.
nounced in DD subjects during high sodium but not during low sodium.
AngII responses of MAP and RVR were similar for the genotypes on
either sodium intake, suggesting that enhanced angI conversion is Conversion of maintenance treatment with cyclosporine and predni-
involved in the increased angI responsiveness in DD genotype. We sone to azathioprine or mycophenolate mofetil with prednisone one
conclude that high sodium intake reveals phenotype differences in year after kidney transplantation. P.J.H. Smak Gregoor, T. van Gelder,
ACE I/D polymorphism, suggesting altered adaptation to high sodium P. de Kuiper, N.M. van Besouw, B.J. van der Mast, J.N.M. IJzermans,
intake in DD genotype. This could explain discrepancies between W. Weimar. Departments of Internal Medicine I and Surgery, University
different studies. Hospital Rotterdam, The Netherlands. In Rotterdam renal transplant
patients have been routinely converted from cyclosporine (CsA) and
prednisone (pred) maintenance therapy to azathioprine (AZA) and
prednisone one year after transplantation. Because of the promisingThe influence of mycophenolate mofetil on the incidence and severity
of cytomegalovirus primo-infections after renal transplantation. C.G. results in the literature with mycophenolate mofetil (MMF) we com-
pared the effects of conversion from CsA1pred to MMF1pred withter Meulen, J.F.M. Wetzels, L.B. Hilbrands. Department of Nephrology,
University Hospital Nijmegen, The Netherlands. Background: Myco- conversion from CsA1pred to AZA1pred, one year after kidney
transplantation. To further reduce the total immunosuppressive load,phenolate mofetil (MMF) is increasingly used for immunosuppression
after renal transplantation (RTx). It was our impression that concur- a 25% reduction in the AZA and MMF dose was performed 4 and
8 months after conversion. All patients with stable graft function,rently with the introduction of MMF, we encountered more cytomega-
lovirus (CMV) related problems in our renal transplant population. transplanted between September 1995 and January 1997, treated with
CsA1pred were randomized for conversion to either MMF1pred (n 5The aim of our study was to investigate if the use of MMF has resulted
in an increase in the frequency and severity of CMV primo-infections. 36) or to AZA1pred (n 5 30). After starting MMF 1 gram bid or
AZA 2 mg/kg/day the CsA-dose was gradually tapered and stoppedMethods: Retrospective study of adult RTx patients who were CMV
seronegative and who received a kidney of a CMV seropositive donor after 4 weeks. The median follow-up is 12 months after conversion.
Acute rejections occurred in 3/36 patients in the MMF vs 8/30 in thein the period of 1992–1997 (n 5 96). 24 of these patients were treated
with MMF (in combination with cyclosporine and prednisone; MMF1) AZA group within the first 4 months (P 5 0.09). The first dose reduction
was not complicated by acute rejection, the second dose reduction wasand the other 72 were the control group (MMF2). No CMV prophy-
laxis was given. CMV infection was defined as CMV seroconversion. complicated by acute rejection in 2/18 MMF and 0/16 AZA patients.
Six rejections responded to one course of methylprednisolone (2 MMF,CMV disease was defined as CMV infection and fever in combination
with one or more of the following: leucocytopenia, thrombocytopenia, 4 AZA), five rejections responded to two courses of methylpredniso-
lone (2 MMF, 3 AZA). Two patients (MMF/AZA) required ATGelevated alanine aminotransferase, or histologic evidence of tissue
invasive disease. Results: The incidence of CMV primo-infections was treatment within 4 months after conversion, with graft loss for one
patient in the MMF group. In 12 patients CsA was restarted: in 5similar in both groups. (MMF1: 67%, MMF2: 65%). CMV disease
was more frequent in the MMF1 group than in the MMF2 group patients as a result of side effects of MMF, in 7 patients after rejection
(2 MMF, 5 AZA). The incidence and severity of side effects associated(58% versus 31%, p , 0.05). In the patients with CMV disease, the
use of MMF did not affect severity of symptoms, frequency of tissue with the use of MMF and AZA were similar, except for the occurrence
of anemia and/or leucopenia (MMF 7/36 vs 12/30 AZA; P 5 0.1). Theinvasive disease and frequency or duration of treatment with gan-
ciclovir. Conclusions: Addition of MMF to the immunosuppressive median serum creatinine decreased from 131 to 107 uM in the MMF
group and from 123 to 106 uM in the AZA treated patients 6 monthstherapy after RTx did not result in an increase of CMV primo-infec-
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after conversion. In conclusion, conversion of CsA1pred to analysed for the several parameters. TERalb was increased in DP (5.5
6 2.5 vs 4.4 6 1.4%/hr. in C, p 5 0.01). Results are given in the table.MMF1pred 1-year after kidney transplantation improves renal func-
tion and is at least as effective and safe as conversion to AZA1pred.
ANOVA
Proteinase 3, the major autoantigen in Wegener’s granulomatosis, between
binds to human umbilical vein endothelial cells in vitro. M.E.J. Controls DPlow DPintermed DPhigh DP
Taekema-Roelvink, C. van Kooten, W. Schroeijers, E. Heemskerk, M.R.
TERalb %/hr 4.4 6 1.4 3.5 6 0.7 5.0 6 0.5 8.1 6 2.7 —
Daha. Dept. of Nephrology, Leiden University Medical Center, P.O. UAE lg/min 5.3 6 2.5 5.8 6 1.4 5.6 6 2.0 5.2 6 1.7 NS
Box 9600, 2300 RC Leiden, The Netherlands. Wegener’s granulomatosis HbAlc % 4.9 6 0.4 8.3 6 1.3 8.5 6 1.3 7.9 6 1.6 NS
is an autoimmune disease characterized by crescentic necrotizing glo- SBP mmHg 116 6 7 116 6 10 117 6 6 119 6 10 NS
merulonephritis and systemic vasculitis. Proteinase 3 (PR3), a neutral DBP mmHg 63 6 5 63 6 7 61 6 4 63 6 7 NS
serine proteinase present in the a-granules of neutrophils, is the main GFR ml/min 106 6 11 122 6 21 119 6 18 118 6 11 NS
target antigen for anti-neutrophil cytoplasmic antibodies (ANCA). FF % 20.6 6 3.0 21.3 6 2.8 21.0 6 2.9 24.2 6 3.8* P 5 0.03
PR3 has been shown to enhance IL-8 production by HUVEC in vitro, FBF ml/min/dl 2.0 6 0.6 2.6 6 0.8 3.0 6 0.9 3.7 6 1.4* P 5 0.04
independently of its enzymatic activity, suggesting a receptor mediated PORH ml/min/dl 41 6 12 39 6 7 40 6 11 46 6 9 NS
effect. In order to obtain insight in the action of PR3 on endothelial ACh/PORH % 50 6 24 49 6 29 47 6 27 67 6 24 NS
cells, we investigated the binding characteristics of PR3 to HUVEC.
Values are expressed as means 6 SD; SBP, systolic blood pressure; DBP,HUVEC were cultured until confluence and subsequently detached diastolic blood pressure; GFR, glomerular filtration rate; FF, filtration fraction;
with PBS containing 10 mM glucose and 20 mM EDTA. Binding of Ach PORH, ratio ACh mediated vasodalatation and PORH.
digoxigenin (DIG) labeled PR3 was detected with FITC-conjugated
sheep Fab anti-DIG and analyzed by flow cytometry. PR3-DIG was
In conclusion, TERalb is increased in normoalbuminuric Type 1 diabe-found to bind to 7 out of 8 primary cell lines. PR3-DIG also bound
tes patients. In DP with an increased TERalb there is no evidence ofto other cell types, such as EAHY926, U937 and A549, but not to
endothelial dysfunction or vessel wall damage. However, both forearmJurkat or renal proximal tubular epithelial cells. No significant binding
blood flow and filtration fraction are increased. Therefore, the in-of DIG labeled myeloperoxydase or bovine serum albumin to HUVEC
creased vascular permeability in the early phase of Type 1 diabetes iscould be detected. Furthermore, binding of PR3-DIG to HUVEC was
mediated by alterations in systemic and renal hemodynamics.significantly reduced in the presence of a 10 M excess of unlabelled
PR3, indicating specificity of binding. PR3-DIG bound to HUVEC in
a dose-dependent manner with 98% of cells being positive for PR3-
Randomised clinical trial between stent placement and balloon angi-DIG at a concentration of 20 mg/ml. Dose-dependent binding of PR3-
oplasty in atherosclerotic renovascular hypertension. J.J. Beutler,DIG to HUVEC could also be detected by cell-ELISA. Treatment of P.J.G. van de Ven, F.J.A. Beek, R. Kaatee, A.J. Woittiez, W.P.Th.M.
HUVEC with trypsin or dispase abolished the binding of PR3-DIG Mali, H.A. Koomans. Depts of Nephrology and Hypertension and Radi-
to the cells as detected by FACS, suggesting the PR3 binds to a protein ology, University Hospital Utrecht, Utrecht, The Netherlands. Objective:
present on endothelial cells. In order to characterize the proteins in- To investigate whether stent placement reduces the rate of restenosis,
volved in binding of PR3 to endothelial cells, biotin-labeled solubilized increases primary patency and improves clinical outcome as compared
membranes of HUVEC were affinity precipitated with PR3 or human to balloon angioplasty in atherosclerotic ostial renal artery stenosis.
serum albumin coupled to Biogel A5 and precipitated proteins were Design and Methods: We randomly assigned 84 hypertensive patients
analyzed by gel electrophoresis and Western blotting. Precipitation of with haemodynamically significant (positive captopril renography or
membrane proteins of HUVEC with PR3-Biogel A5 revealed two deterioration renal function during ACE-inhibition) atherosclerotic
bands of 111 and 56 kD. Our study shows a concentration-dependent ostial renal artery stenosis (stenosis .50% within 10 mm of the aortic
and cell-type specific binding of PR3 to HUVEC in vitro, which may wall) to stent placement or to balloon angioplasty. Control angiography
involve membrane proteins of 111 and 56 kD. Further characterization was performed immediately after the procedure and at six months (or
of these proteins is currently under investigation. earlier if on clinical grounds a restenosis was suspected). Blood pressure
and plasma creatinine was measured before treatment and at the time
of control angiography. Results: The stented patients had a higher
rate of procedural success rate than those who underwent balloonTranscapillary escape rate of albumin is increased and related to hemo-
angioplasty (88%, 37/42, vs 57%, 24/42, P , 0.05) and had a lowerdynamic changes in normo-albuminuric Type 1 diabetes patients. G.
rate of restenosis at six months (14%, 5/35 vs 48%, 11/23, P , 0.01).Vervoort, J.F.M. Wetzels, J.A. Lutterman, P. Smits, J.H.M. Berden.
After six months cumulative primary patency was significantly betterDept. of Medicine, University Hospital Nijmegen, St Radboud, The
in the stented patients as compared to those treated with angioplastyNetherlands. It has been suggested that an increase in urinary albumin
(74%, 29/39 vs 29% 12/41, P , 0.01). The patients in stent groupexcretion (UAE) reflects widespread vascular dysfunction in Type 1
as compared to those treated with angioplasty had similar rates ofdiabetes patients. Indeed, transcapillary escape of albumin (TERalb),
normalisation (blood pressure # 160/90 mmHg) or improvement (falla measure of systemic capillary leakage, is increased in diabetic patients
of mean arterial pressure of $20%) of hypertension (56%, 23/35 vswith micro- and macroalbuminuria. Diabetic patients with even a mod-
65%, 15/23, NS) and improvement (fall in plasma creatinine $ 20%)est increase of UAE .20 mg/min have a 50% increase of TERalb.
or stabilisation (,20% change plasma creatinine) of renal functionWe hypothesized that TERalb might be the most sensitive marker of (77%, 27/35 vs 78%, 18/23, NS). Conclusion: Stent placement, as com-
vascular permeability changes, being already increased in the phase pared to angioplasty, resulted in a superior patency of the treated renal
preceding microalbuminuria as a consequence of alterations in hemo- artery. However, at short term follow-up (6 months) this was not
dynamics, endothelial cell function or vessel wall properties. We mea- accompanied by a better effect on blood pressure or renal function.
sured TERalb in 39 normoalbuminuric (UAE ,10 mg/min) Type 1
diabetes patients (DP) with a disease duration between 5–12 years and
47 healthy controls (C). TERalb was calculated from the disappearance Expression of agrin in the glomerular basement membrane in human
curve of 125I-albumin. Arterial blood samples were drawn to improve glomerular diseases. B.A. Yard§, S. Resch§, S. Kahlert§, J. Berden*, J.
this method. Renal and systemic hemodynamics were measured by van der Born*, S. Kro¨ger#, R. Waldherr§, and F.J. van der Woude§.
standard techniques. Forearm blood flow (FBF) was measured by §University of Heidelberg, Germany; *Department of Nephrology, Nij-
plethysmography. Endothelial function was assessed by intra-arterial megen, The Netherlands; #Max Planck Institut for brain research, Frank-
infusion of acetylcholine (ACh). The structural integrity of the vessel furt, Germany. In biopsies of patients with diabetic nephropathy (DN),
wall was determined by the post-occlusive reactive hyperaemia test we have demonstrated a selective loss of heparansulfate glycosaminog-
lycans (HS-GAG) side-chains (Tamsma et al, Diabetologia 37:313,(PORH). DP were divided in tertiles with respect to TERalb and
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1994). Recently it became evident that agrin, but not perlecan is the is estimated that this pattern accounts for 40% of the cases of dialysis
hypotension. Spectral analysis of heart rate variability (HRV) has beenmajor HSPG in the glomerular basement membrane (GBM) (Groffen
et al. 46:19, 1998). We therefore studied glomerular Agrin expression advanced as a non-invasive tool to describe sympathovagal balance.
The high-frequency (HF) component of HRV is a marker of efferentin patients with various nepropathies. The glomerular distribution of
agrin was investigated on cryostat sections of human renal tissue. In vagal activity, the low-frequency (LF) component a putative marker
of sympathetic modulation. LF/HF ratio is considered to reflect sympa-this study, 81 biopsies with different glomerulopathies (DN n 5 15,
SLE n 5 13, IgA nephropathy n 5 13, membranous glomerulonephritis thovagal balance. We used this method to assess changes in sympatho-
vagal balance before and during symptomatic dialysis hypotension. In(MG) n 5 13, minimal lesions disease (ML) n 5 14) and healthy
controls (n 5 13) were included. In normal controls a homogeneous 41 sessions (16 hypotension-prone patients) 17 hypotensive periods (9
patients) occurred (41%). From the start of dialysis and ultrafiltrationlinear staining for agrin (AS 46) was detected. There was no difference
in the expression of this antigen in biopsies from patients with MG and until 209 before hypotension we observed a gradual decrease in MAP
(24,8%) accompanied by increases in heart rate (9,2%), LF variabilityML. However in patients with IgA nephropathy and DN a significant
decrease in agrin was found (p , 0.001, students t-test). We conclude (in normalized units, nu) and LF/HF ratio. Shortly before hypotension
these changes were even more pronounced. During hypotension heartfrom these data, that glomerular agrin expression in the GBM is de-
creased in diabetic- and IgA nephropathy patients. This finding argues rate decreased (221,9%) together with LF/HF ratio and LF (nu). HF
(nu), marker of vagal activity, strongly increased.against a selective dysregulation in HSPG sulfation as postulated by
Deckert et al. On the contrary, our findings suggest that an altered
agrin production or turnover could play a pivotal pathogenic role in
DN and IgA nephropathy. start 209 before 109 before hypotension 109 after
MAP mmHg 100 (4.6) 94 (4.2) 88 (4.2) *#57 (2.1) 74 (5.3)
HR bpm 77 (2.2) 84 (2.6) 89 (2.7) *#69 (2.7) 73 (3.1)The growth factors VEGF and TGFb-1 in peritoneal dialysis. M.M.
LF nu 38.2 (5.7) 48.1 (4.1) 62.0 (5.5) *36.9 (4.0) 50.1 (5.9)Zweers, D.R. de Waart, D.G. Struijk, R.T. Krediet. Academic Medical
HF nu 61.4 (5.4) 51.9 (4.1) 38.0 (5.5) *63.1 (4.0) 49.9 (5.9)Center, Amsterdam, The Netherlands. The morphological alterations
LF/HF 0.87 (0.2) 0.98 (0.1) 2.54 (0.5) *0.59 (0.1) 1.79 (0.5)in the kidney and the retina that can be present in patients with diabetic
microangiopathy are mediated by growth factors. Vascular endothelial Data are mean (6 se), * P , 0.05 vs 10 before hypotension, # P , 0.05 vs baseline
growth factor (VEGF) is a mediator of neoangiogenesis in diabetic
retinopathy. TGF-b is involved in the extracellular matrix proliferation
in diabetic nephropathy. The aim of the present study was to investigate A most remarkable finding was that all patients experiencing hypoten-
VEGF and TGF-b1 in peritoneal effluents of PD patients treated sion showed this pattern of high LF/HF ratio in the compensated phase
with glucose containing dialysis solutions, in relation to parameters of (MAP modestly low), followed by low LF/HF ratio in the decompen-
peritoneal transport. Standard peritoneal permeability analyses using sated phase (MAP strongly decreased). These findings suggest that,
3.86% glucose dialysate, were performed in 16 stable PD patients in contrast with current ideas, vagal activation/sympathic inhibition
(median duration of PD 39 months, range 1–104). The power relation is a universal phenomenon in sudden dialysis hypotension. Further
that is present between dialysate/serum (D/S) ratios of serum proteins research has to be done to elucidate the origin of this Bezold-Jarisch
that are only transported across the peritoneal membrane and their like reflex.
molecular weights was used to predict the D/S ratio’s when diffusion
would be the only explanation of the measured dialysate concentration.
It was appreciated that all TGF-b1 in the circulation was bound to Complement activation and expression of leukocyte surface molecules
a2-macroglobulin. D/S ratio’s of VEGF (p , 0.0005) and TGF-b1 during hemodialysis with unmodified cellulose membranes. A. Dhondt,
(p , 0.015) were significantly higher than expected when VEGF and R. Vanholder, C. Tielemans, M. Waterloos, G. Glorieux, N. Lameire.
TGF-b1 would only have been transported from the circulation by Renal Division, Department of Internal Medicine, University Hospital
diffusion. The local production of the growth factors in the peritoneal Gent and Brussels, Belgium. Background: Dialysis with complement
membrane was assessed as Dmeasured-Dpredicted. No relationship was present activating membranes is associated with leukopenia, which is related
between the local production of VEGF (LVEGF) and that of to an increase of adhesion molecule expression on leukocytes. Citrate
TGF-b1 (LTGF-b1). LVEGF (median 15.8 ng/L, range 6.51–28.36 chelates calcium and has been claimed to attenuate dialyzer bioincom-
ng/L), correlated with the MTAC creatinine (9.87 mL/min, 6.61–15.23 patibility. Methods: In this study, the effect of citrate anticoagulation
mL/min), a reflection of peritoneal vascular surface area: r 5 0.69, p , on leukocyte and granulocyte counts, complement activation and the
0.007. A negative correlation was observed between the transcapillary expression of CD11b, CD11c and CD45 on the surface of granulocytes
ultrafiltration (926 mL/4 hr, 394–1262 mL/4 hr) and LVEGF (r 5 was evaluated during the first 15 minutes of hemodialysis with unmodi-
20.52, p , 0.045). This negative trend was also observed between the fied cellulose membranes. In 8 chronic hemodialysis patients, standard
net ultrafiltration (622 mL/4 hr, 243–938 mL/4 hr) and LVEGF (r 5 heparin was compared to citrate in three different schedules. Citrate
2 0.48), but did not reach significance (p , 0.06). LVEGF and duration was infused to obtain a concentration of either 7 or 10 mmol/l blood.
of treatment did not correlate, possibly because the relative small CaCl2 was administered to recalcify the blood returning to the patient
number of patients. LTGF-b1 showed no relation with transport pa- at 8.25 mmol Ca11/h (citrate 10 mmol/l) or at 11 mmol Ca11/h (citrate
rameters or duration of treatment. In conclusion we found evidence 7 and 10 mmol/l). Results: The use of citrate at a high concentration
for local production of both VEGF and TGF-b1 in the peritoneal (10 mmol/l) was associated with a blunted upregulation of CD11b,
membrane of patients using chronic peritoneal dialysis with glucose both at the inlet and at the outlet bloodline; for CD11c a reduced
based dialysate solutions. VEGF was likely to be involved in the neoan- upregulation was observed on granulocytes harvested from the inlet
giogenesis of the peritoneum that is present in some long-term PD bloodline. The use of citrate did not result in a blunted leukopenia,
granulocytopenia or complement activation. A positive correlationpatients. The analogy with VEGF in diabetic retinopathy further sup-
ports a pathogenetic role of high dialysate glucose concentrations in between the decrease in systemic ionized Ca11 concentration and the
increase in CD11b and CD11c expression was observed. Conclusion:the development of these alterations in the peritoneal membrane.
We conclude that although citrate/CaCl2 administration affects leuko-
cyte adhesion molecule expression in a dose dependent way, no effect
Heart rate variability during dialysis hypotension: confirmation of Be- could be demonstrated on leukopenia and complement activation.
zold-Jarisch like reflex. M.G.W. Barnas, W.H. Boer, L.J. van Schelven,
H.A. Koomans. Dept. of Nephrology and Hypertension, University
Hospital Utrecht, The Netherlands. Dialysis hypotension, defined as a Pro-IL-1b processing and secretion rather than its synthesis are in-
creased in peritoneal macrophages from CAPD-patients with peritoni-drop of mean arterial pressure (MAP) below 65 mmHg with typical
symptoms, may occur in association with paradoxical bradycardia. This tis. M.W.J.A. Fieren, W.W. Mol, C.C. Baan, W. Weimar. Department of
Internal Medicine I, University Hospital “Dijkzigt”, Erasmus Universityevent is compatible with activation of a Bezold-Jarisch like reflex
(BJR), which involves sudden withdrawal of sympathetic activity. It Rotterdam, Rotterdam, The Netherlands. Previously we reported, that
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peritoneal macrophages (PMØ) isolated from CAPD patients during period (3 sessions/week) had a double cross-over design: 1 week DP,
1 week SP, 1 week DP, 1 week SP. The pump speed was aimed at 500an episode of peritonitis (P) have an increased capacity (are “primed”)
to release IL-1b after stimulation in vitro with LPS, as compared to ml/min for both arterial and venous pump in DP and 500 ml/min in
SP. In SP the mean urea reduction rate (URR) was 2.3% lower thanPMØ from an infection free period (IFP). In order to investigate the
molecular mechanisms of priming of PMØ, we studied IL-1b mRNA in DP [63.86 6 0.07% vs 65.35 6 0.07% (p , 0.05)] in spite of the
larger processed blood volume/session as indicated by the monitor:expression as well as production and secretion of the bioactive mature
IL-1b (mIL-1b) and its precursor pro IL-1b by infection-free and 57 6 10 vs 44 6 61 (p 5 0.001). Bloodflow and processed blood
volume indication is overestimated in SP-modus as no correction forinfectious PMØ. Cells were isolated during IFP’s and P’s and incubated
(106 PMØ) with 5 mg/ml of LPS. Pro-IL-1b and m IL-1b levels were the negative pressure in the arterial blood line and possible partial
collaps of the pump segment is applied. This could falsely give themeasured in celllysates and in supernatants using specific ELISA’s; IL-
1b mRNA levels were quantitated exactly using a competitive reverse impression that SP is more effective than DP. However, we demon-
strated that in single lumen catheter dialysis DP-modus is more effec-transcriptase polymerase chain reaction (RT-PCR). In supernatants
m IL-1b was 2695 6 595 pg/ml/106 cells (M 6 SEM) and 16 612 6 tive than SP-modus.
8622 pg during 8 IFP’s and 10 P’s respectively (P , 0.05). In lysates
pro IL-1b was 12824 6 1885 pg/106 cells and 7748 6 2144 pg during
IFP and P (p 5 0.05) respectively. Total IL-b production (pro-IL-1b Effects of losartan on factor XII and C1-esterase inhibitor during
hemodialysis with PAN membranes. J.G.A. Wiering, M. Schoorl,1 m IL-1b in supernatants 1 lysates), expressed in pmol, did not differ
significantly between these groups. However, the fraction of total IL- P.C.M. Bartels, M. Schoorl, M.P.C. Grooteman, J. van Limbeek, M.J.
Nube´. Medical Center Alkmaar, Alkmaar, The Netherlands. Introduc-1b, released as m IL-b was significantly higher for PMØ from peritonitis
patients (23 6 3.6%) than for infection free PMØ (57 6 7.6%) (p , tion: Severe anaphylactoid reactions have been described in HD pa-
tients who were dialyzed on PAN membranes and treated with ACE0.005). IL-1b mRNA expression in PMØ from IFP and P, did not
differ significantly: m RNA levels were 382 and 97 attomoles/105 cells (5 kininase II) inhibitors. Defective clearance of bradykinins (BK) is
thought to play a crucial role. This process, mediated by kallikrein,in infection free and peritonitis PMØ respectively (N.S). In conclusion:
In LPS stimulated PMØ from peritonitis patients processing and export is controlled by both activated factor XII and C1-esterase inhibitor.
Recently, angiotensin (AII) receptor antagonists have been developed.of IL-1b rather than its production are increased, pointing to the key
role of processing in the regulation of IL-1b activity in MØ during In contrast to ACE inhibitors (ACEi), these drugs do not interfere
with the degradation of BK, both in patients with normal renal functioninfection.
and uremia. However, so far it is not known to what extent the contact
activation pathway is influenced by the simultaneous use of AII recep-
tor antagonists and PAN membranes. Patients and methods: The firstEffect of intravenous saline, albumin or hydroxyethylstarch on plasma
volume preservation during combined ultrafiltration/haemodialysis. phase of the contact activation pathway, as indicated by the concentra-
tions of coagulation factor XII and C1-esterase inhibitor, was studiedF.M. van der Sande, J.P. Kooman, J.N.M. Barendregt, F.H.M. Nie-
mann*, K.M.L. Leunissen. Department of Internal Medicine and *Staff during the first 30 min of HD. Nine patients, who were dialyzed on PAN
devices, were cross-over randomized to antihypertensive treatmentBureau, University Hospital Maastricht. It is generally advocated to
use saline (0.9%) or albumin (20%) infusions during symptomatic containing Losartan or other (non-ACEi) medication. Results: As for
factor XII, immediately after the start of HD (t1) a highly significanthypovolemia. Because of the attendant side effects and/or costs they
are limited for chronic use. Hydroxyethylstarch (HES) is used on the difference was observed between the concentrations in the arterial
(t1a) and venous (t1v) lines (t1a 81 6 25% vs t1v 60 6 20%; p , 0.001).ICU in the management of hypovolemia with a potent volume effect
up to 4 hours. So, it can be expected that HES might also be of clinical Moreover, the concentrations in the arterial line at t5 and t30 were
significantly lower if compared with t1: resp 56 6 19% and 61 6 17%importance in dialysis patients. Therefore, the efficacy of 3 solutions on
plasma volume preservation (PV), blood pressure (SBP) and vascular vs 81 6 25%; p , 0.001. As for C1-esterase inhibitor, a comparable
pattern was observed: immediately after the start of HD a significantreactivity (venous tone, VT) was compared. An iv injection (t 5 iv)
of 100 ml saline (0.9%), albumin (20%) or HES (Hes-steril 10%, difference was observed between t1a and t1v (resp. 99 6 12% vs 94 6
9%; p 5 0.04). Furthermore, the concentrations in the arterial line atFreseniusR, Den Bosch, The Netherlands) was given when the decrease
in relative blood volume (BV) was more than 10% measured with t5 and t30 were significantly lower, if compared with t1: resp. 95 6 12%
and 92 6 18% vs 99 6 12%; p , 0.01. Conclusions: During HD withCrit-line (In-line Diagnostics, Riverdale). Dialysis was standardised:
individual bicarbonate, sodium and temperature. Statistical analysis: PAN membranes, the first phase of contact activation is characterized
by a marked decrease across the dialyzer of both factor XII and C1-repeated measurements (M)anova. Time of infusion of the iv fluid was
comparable between saline, albumin and HES (140, 155 and 151 min). esterase inhibitor. The initial decrease of both substances was sustained
in the arterial line during the first 30 min of HD. Differences were notBV (%) decreased significantly during UF 1 HD independent of which
fluid was infused (saline; 215.03 6 0.3, albumin; 212.50 6 2.6, HES; observed between Losartan and other (non-ACEi) antihypertensive
medication. These data indicate that Losartan, in contrast to ACEi,211.21 6 2.25). However, the decrease was significantly higher when
using saline compared to albumin and HES. Between albumin and does not interfere with the first phase of HD-induced contact activation.
HES there were no significant differences. With saline SBP (mmHg)
tended to decrease more versus baseline (228 6 39) as compared to
Vascular and interstitial changes in a continuous peritoneal infusionalbumin (29 6 22) and HES (28 6 19), although the difference was
model in the rat. M.M. Zweers, J.B. Mulder, R.T. Krediet, D.G. Struijk.not significant. VT (mmHg/ml/dl) increased significantly with isotonic
Academic Medical Center Amsterdam, The Netherlands. A chronicsaline (17.5), and remained unchanged with albumin (10.5) and HES
experimental peritoneal infusion model in the rat was developed to(12.2). We conclude that HES is a promising fluid in preserving plasma
investigate vascular and interstitial changes of the peritoneal mem-volume, being comparable to albumin but superior to saline. Further
brane caused by continuous exposure to glucose containing dialysate.studies in hypotensive prone patients are needed to look at the effect
A vascular acces port (Rat-o-Port) with an attached peritoneal catheteron blood pressure course during haemodialysis.
was implanted subcutaneously in the neck of 19 non-uremic, non-
omentectomized male Wistar rats (297 g, SD 21 g). Three groups were
investigated: group 1 (n 5 9): daily infusion of 3.86% glucose containingSingle lumen catheter dialysis: single blood pump (click-clack) com-
pared to double blood pump. N. Veys, W. Van Biesen, N. Lameire. dialysate (60 mL/kg BW) via the Rat-o-Port; group 2 (n 5 6): daily
exposed to Ringer’s lactate (60 mL/kg BW); group 3 (n 5 4): controlUniversity Hospital Gent, Belgium. In ESRD-patients with vascular
access problems catheter dialysis is often an acceptable alternative. group without catheter. At time t 5 0, 12, 16, 20 weeks after start of
ip infusion, rats of group 1 (n 5 3 per time point) and 2 (n 5 2 perIn 13 clinically stable chronic hemodialysis patients with one single
tunneled 12 F 3 40 cm single lumen silicon Tesio catheter (Curamedt, time point) were sacrificed. Control group 3 was examined at time t
5 0 (n 5 2) and t 5 20 (n 5 2) weeks after inclusion. The parietalHasselt, Belgium) as vascular access we investigated the dialysis effi-
ciency in single pump (click-clack) (SP) vs double pump (DP) modus peritoneum and omentum were investigated for presence and type of
fibrous tissue (Sirius Red, type IV collagen, aSMA) and for neoangio-with the AK100 monitor (Gambrot, Lund, Sweden). The 4 week study
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genesis (factor VIII) in all rats. Only few vessels, and little fibrous the observed slope of either 1000/Cr or ClCockr using the correlations
found, i.e. calculated from the respective regression equation.tissue of fibrillar collagen was found perivascular and intersegmental
in the biopsies of control group 3. No collagen IV was observed. There
was no difference between t 5 0 and t 5 20 in this group. After 20
weeks exposure to Ringer’s lactate the omental and parietal sections 1000/creat slope GFR slopepred Cockcroft slope GFR slopepred
1000/lmol/year ml/min/year ml/min/year ml/min/yearwere similar to those of the controls. However, a substantial increase
in fibrous tissue and in the number of vessels after 16 and 20 weeks 1.0 3 (25/111)* 0 24 (211/13)*
of exposure to glucose based dialysate was found in group 1. Collagen 0.0 24 (212/14)* 25 29 (215/22)*
IV was found in vessel walls and in the collagenous layer. Electron 21.0 210 (218/22)* 210 213 (220/26)*
microscopy revealed profound lamination of the basal lamina of capil- 22.0 217 (225/29)* 215 218 (225/211)*
laries after 20 weeks of glucose exposure which was not present after
* 95% confidence interval of the predicted GFR slope20 weeks in group 2 and 3. In conclusion, this rat model can be used
to investigate effects of chronic exposure of dialysis fluids on the mor-
phology of the peritoneal membrane. The neoangiogenesis, lamination Patients with a stable renal function, as estimated from 1000/Cr slope
of basal membranes and the presence of collagen IV in vascular walls, or Cockcroft slope, may in fact have a GFR slope of 24 ml/min/yr as
apparent from the table. Moreover, large interindividual variabilityresemble the findings in some longterm PD patients and are consistent
leads to a wide confidence interval of the predicted GFR slope. Thus,with glucose induced diabetiform microangiopathy.
creatinine-based monitoring correlates with serial GFR measurement,
but underestimates the rate of renal function loss. These inaccuracies
have to be considered, when monitoring renal function in this high-
Modulation of ATR1 mediated Ca signaling in mesangial cells by risk population.
glycosaminoglycans. B.A. Yard*, H. Ko¨ppel*, M. Crist*, M. Wehling*,
F.J. van der Woude. V. Med. Klinik, Klinikum Mannheim, University
Fasting and non-fasting oral bioavailability of tacrolimus before andof Heidelberg, Germany. In the present study we addressed the question
after renal transplantation in diabetics and non-diabetics. E. v. Duijnho-if heparin and/or glycosaminoglycans (GAGs) or glucose are able to
ven*, M. Christiaans, N. Undre, J. v. Hooff. Department of Internalmodulate the ANG II induced intracellular calcium (Ca21i) signaling
Medicine, University Hospital Maastricht, The Netherlands, and Fuji-in human mesangial cells (MC). Mesangial cells were isolated from the
sawa GmbH, Munich, Germany. In liver recipients oral bioavailabilityrenal cortex and cultured in DMEM with 20% FCS. For intracellular
of tacrolimus (FK) decreases when FK is taken after food. Data forcalcium measurements the cells were grown on fibronectin coated renal recipients are lacking. Especially diabetes might influence bio-
slides in the absence of FCS. Ca21i was measured by the Fura-2 method. availability because of disturbed gastrointestinal motility. Therefore
100 nM ANG II resulted in a rapid increase in Ca21i followed by a we addressed 4 questions: 1 Influence of diabetes on bioavailability of
decline to baseline level. Addition of heparin or GAGs resulted in an FK 2 influence of food on bioavailability both in diabetics and non-
oscillatory pattern of Ca influxes upon ANG II stimulation. Heparin diabetics 3 influence of food on bioavailability at different times after
alone did not induce a Ca influx. Normal and oscillatory Ca spikes transplantation 4 longterm influence of food on trough levels of FK.
were completely blocked by losartan, not by PD123319. ANG II stimu- Patients and methods: The effect of diabetes and food on bioavailability
lation of MC, cultured in the presence of NaClO3 to inhibit sulfation was assessed comparing blood concentration-time profiles (AUC(0–12),
cmax and tmax) made on 2 consecutive days (fasting and non-fasting). Toof cellbound GAGs, resulted in an oscillatory pattern. Addition of
avoid confounding factors due to operation and co-medication, 7 typeheparin to these cultures completely restored the normal Ca influx
1 diabetic and 10 non-diabetic dialysis patients were studied beforepattern. Since D-glucose inhibits mesangial HSPG production, we
transplantation. After transplantation 14 patients were studied at 3tested MC after a three days culture with 25 mM D-glucose. Again
weeks, 6 and 12 months. Thereafter they were allowed to take FKan oscillatory pattern was observed after ANG II, which could be
together with food in the morning and evening. Conclusions: 1 Pretrans-restored to normal with heparin. Conclusions: ATR1 mediated Ca
plantation in diabetics compared to non-diabetics, fasting AUC of FKsignaling in MC is modulated by GAGs. After addition of exogenous
was 38% lower (p 5 0.11). 2 Pretransplantation when FK was takenGAGs or after desulfation of endogenous GAGs, ANG II leads to together with breakfast compared to fasting in non-diabetics resp.
an oscillatory Ca influx. These findings might be of relevance in the diabetics, Cmax decreased 22 resp. 44% and tmax increased 50 resp. 100%,pathogenesis of hypertension and nephropathy in diabetic patients, however, AUC remained unchanged. 3 Posttransplantation there was
since they lack glomerular heparansulfat-GAG and ACE inhibitors a decrease in non-fasting AUC values of approximately 2% at week
and GAGs have been shown to have a beneficial effect on bloodpres- 3, 12% at month 6 and 9% at month 12 (p 5 ns). 4 When it was
sure and proteinurie. allowed to take FK together with food there was a 615% decrease
in trough level, but in all patients trough level remained within the
therapeutical window.
Validity of slopes calculated from reciprocal serum creatinine
(1000/Cr) or cockcroft clearance (ClCockr) in detecting rate of renal Influence of tacrolimus (FK) on glucose metabolism before and after
function loss after lung transplantation. J. Broekroelofs, J. de Haan, renal transplantation, a prospective study. E. v. Duijnhoven, M. Chris-
C.A. Stegeman, G.J. Navis, W. v.d. Bij, D. de Zeeuw, P.E. de Jong. tiaans, F. Nieman, B. Wolffenbuttel, J. v. Hooff. Department of Internal
Medicine, University Hospital Maastricht, The Netherlands. To gainUniv. Hospital Groningen, The Netherlands. Changes in renal function
information on relative diabetogenicity of FK and Cyclosporin Aare best detected with serial GFR measurements. In clinical practice
(CyA) we assessed insulin sensitivity index (Kg) and insulin andcreatinine-based methods are more convenient, but their reliability is
C-peptide secretion capacity by intravenous glucose tolerance testquestioned, due to influence of body mass, tubular handling of creati-
(ivgtt) in two studies. Material and methods: 1 before transplantation,nine, and diet. After transplantation, these factors are often not con-
to avoid confounding factors, 9 dialysis patients were tested by ivgttstant. To investigate the validity of creatinine-based monitoring of
before and after 5 days exposure to FK. 2 after renal transplantation,renal function in lung transplant (Ltx) recipients, we analyzed the slope
23 patients were prospectively studied by ivgtt 3 weeks, 3 and 6 months,
of GFR, of 1000/Cr and of ClCockr measured every 6 months after Ltx 1, 2 and 3 years after transplantation: 11 were randomised receiving
in 40 patients (43 6 10 yr) with a follow up of at least 24 months. FK, 12 CyA. Dosage of concomitant immunosuppression was the same
Slopes were calculated from 6 months onwards. The median slope of in both groups. HbA1c and fructosamine were also measured. Results:
GFR was 26 ml/min/yr (range 220 to 17), of 1000/Cr 20.5 1/umol/ 1 Before transplantation fasting glucose increased from 4.6 to 4.9 mmol/
yr (22.6 to 1.3), and of ClCockr 24 ml/min/yr (216 to 113). The slope l (p 5 0.011) and Kg decreased from 2.16 to 1.13 (p 5 0.008) after
of 1000/Cr (r 5 0.81) and of ClCockr (r 5 0.85) correlated with the slope FK. C-peptide and insulin secretion capacity did not change. In those 7
patients who had a normal Kg before FK, there was a linear correlationof GFR (p , 0.0001). The table shows the GFR slope predicted by
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between Kg after FK and FK trough level (r 5 20.756; p 5 0.05). All trophy (MH) and hyalinosis (HY) on a semiquantitative scale (0–2).
Statistical analysis was performed by nonparametric, uni- and multivar-patients with FK trough levels below 15 ng/ml had a normal Kg. So
far 7 have been transplanted; 2 developed NIDDM. Both already had iate techniques. Results: LES were present in 72% of Bx (GS 27%,
IF 56%, MH 60%, HY 14%). LES were weakly to moderately associ-a low Kg before FK was given. 2 After transplantation fasting glucose,
HbA1c, fructosamine and Kg were not significantly different between ated with each other (r 5 0.19–0.64; p , 0.05). Univariate analysis:
Every LES was significantly associated with age; IF also with gender,the FK and CyA group at any time. C-peptide and insulin secretion
capacity increment values were only lower in the FK group at week COD and NHB; HY with hypotension and COD. GS nearly always
went together with IF, and is reported as GS/IF. HY was only seen3; thereafter the difference disappeared, probably due to lower trough
levels, indicating a reversible decrease of synthesis. Only one patient in combination with MH and GS/IF. LES were grouped into patterns:
A 5 no lesions (75), B 5 only MH (29), C 5 only GS/IF (29), D 5 MH1(CyA) developed NIDDM. Conclusion: 1 Before transplantation FK
causes clinical important disturbance of glucose metabolism only in GS/IF (96), E 5 HY (37). Donorage significantly differed between the
patterns: A and B 5 26–30 yr, C and D 5 40–43 yr and E 5 49 yr.prediabetic patients (low Kg) or with trough levels above 15 ng/ml. 2
Clinically important disturbances of glucose metabolism are reversible Pattern was associated with age and COD in univariate analysis, but
only with age in multivariate analysis. Conclusions: Chronic ischaemicwhen lower dosages of FK are given. 3 After renal transplantation no
significant differences is glucose metabolism between FK and CyA lesions are present in 72% of the grafts. Individual lesions in a biopsy
were grouped into patterns depending on glomerulosclerosis/intersti-were found during 3 years follow-up.
tial fibrosis and/or mediahypertrophy and/or hyalinosis. Mean do-
norage significantly differed between patterns, increasing with presence
Proteinuria in a potential kidney donor: the role of artificial plasma of GS/IF and HY, but not with only MH. Age is the only donorvariable
expanders. M.H. de Keijzer, I.S. Klasen, A.J.W. Branten, W. Hordijk, associated with lesions. Analysis of graft outcome related to these
J.F.M. Wetzels. Department of Clinical Chemistry and Department of variables will be presented.
Nephrology, University Hospital Nijmegen, The Netherlands. Objective:
To study the effects of various artificial plasma expanders on the
measurement of total urinary protein. Background: In the urine of Upregulation of glomerular ecto-59nucleotidase in chronic kidney graft
a patient with confirmed braindeath high amounts of protein were disfunction. K.W. Mui, J.J.H. Oosterhof, W.J. van Son, W.W. Bakker.
measured, ultimately leading to the refusal of the kidneys for trans- Departments of Pathology and Internal Medicine, University Hospital
plantation purposes. Since histological examination of the kidneys did Groningen, The Netherlands. To study patho-mechanisms of glomeru-
not reveal any abnormalities, the role of the infused, modified gelatin lar injury in chronic graft disfunction (CGD), we stained biopsies from
plasma expander was investigated. Methods: A protein free urine was patients with CGD (n 5 13), or normal human kidney tissue for both,
spiked with the plasma expanders Gelofuset (Gelo), Haemaccelt glomerular ecto-ATPase as well as ecto-59nucleotidase (59-nase), using
(Haem) or EloHaest (EloH) in a concentration of 5 g/L. The urinary immunostaining as well as conventional enzyme histochemistry, as
protein concentration of these samples was estimated using the Coo- described previously. We were able to confirm that exclusively in
massie Brilliant Blue (CBB) method, the Pyrogallol Red Molybdate kidney tissue of patients with CGD significantly reduced expression
(PRM) method, the trichloroacetic acid (TCA) method and the biuret of (the oxidant sensitive) glomerular ecto-ATPase occurred concomi-
(BIU) method. Results: With the CBB and the TCA method elevated tantly with enhanced glomerular activity of 59-nase. Since adenosine
protein concentrations were not found, while the results from the PRM release from AMP is catalysed by 59-nase, the question emerged
and biuret method indicated that proteinuria was present. The plasma whether upregulation of 59-nase may function as a counter mechanism
expander EloHaest is based on corn starch and does not react, in of ischemia associated oxidant stress, leading to the local production
contrast to the polypeptides Gelofusinet and Haemaccelt, as urinary of the oxidant scavenger adenosine. To evaluate this possibility in
protein (see table, results are given in g/L). vitro, TNFa stimulated human PMN’s (1 3 106 cells/ml) were incubated
with normal human kidney tissue at 378C for 30 min with or without
superoxide dismutase, (SOD) (30 units per ml), or adenosine (100 mM
per ml) and subsequently washed and stained for glomerular ecto-CBB PRM TCA BIU
ATPase; the amount of reaction product was quantified using compu-
Gelo ,0.1 3.9 ,0.1 4.8 terized image analysis. The results show significant reduction of reac-
Haem ,0.1 3.9 ,0.1 4.7 tion product after incubation with activated PMN’s as compared with
EloH ,0.1 ,0.1 ,0.1 ,0.1 sections incubated with culture medium with or without SOD or adeno-
sine. In contrast, adenosine or SOD added to the activated cells pro-
tected the glomerular ecto-ATPase expression completely. It is con-
cluded that adenosine is able to protect glomerular ecto-ATPase inConclusions: The use of modified gelatin solutions cause apparent
proteinuria when using the pyrogallol and biuret method. This may vitro, probably by scavenging oxygen free radicals. The possible rele-
vance in vivo of upregulation of glomerular 59-nase as a protectivelead to the refusal of otherwise healthy kidneys for transplantation.
Clinical chemists and clinicians should be aware of this phenomenon mechanism for ischemic injury requires further investigation.
and in case of any doubt repeat the analysis with another technique.
Outcome of transplantation of non-heart beating donor kidneys: a
single centre experience. F. van der Sande, M. Christiaans, M. Kho,Incidence of chronic ischaemic lesions in cadaveric donor grafts perop-
erative and their association with donorparameters. M. Kho, M. Chris- Y. Kievit, G. Kootstra, J. van Hooff. Internal Medicine and Surgery,
Univ. Hosp. Maastricht, The Netherlands. Shortage of donor kidneystiaans, R. van Suylen, F. Nieman, J. van Hooff. Department of Internal
Medicine, Pathology, and Methodoloy Section, University Hospital is the main cause of an increasing waiting list. Our centre has a long-
standing experience with the use of kidneys procured from non-heartMaastricht, The Netherlands. Introduction: In cadaveric renal trans-
plantation ‘marginal’ kidneys are increasingly used. Scoring for chronic beating donors (NHB). Multicentre studies have shown acceptable
results of NHB kidneys compared to heart beating (HB) kidneys. Theischaemic lesions (LES) in a renal biopsy might help in the triage,
excluding grafts with poor prognosis. Studies on the incidence of LES purpose of this study is to confirm these results in patients receiving
a transplant in a single centre. Patients and Methods: From 1982 tilland their association with donor demographics and graft outcome are
scarce and small-sized. Patients & methods: From 1982 to 1996 456 January 1997 472 cadaveric kidneys were transplanted (50 from NHB
donors). Outcome parameters were ATN (dialysis ,7 days p.o., noconsecutive cadaveric renal transplants were performed, of which 266
were studied (.7 glomeruli in the 1-hour biopsy (Bx)). Characteristics: of days hospitalized, graft survival (GS), and creatinine clearance.
Statistical analysis: (non)parametric tests and Cox-regression (risk fac-age 38 yr; male 156; non-heart-beating donor (NHB) 20; hypotension
predonation 138; Cause of Death (COD; ET-criteria): trauma 134, tors; NHB donor, age donor, age recipient, mismatch for HLA-DR).
Results: Compared to the HB-group, the NHB-group had a longerSAB 55, CVA 46, tumor 3, other 27, missing 1. Bx were reexamined
blindly by 2 independent observers and scored for glomerulosclerosis WIT1 (43.8 vs. 2.12 min; p , 0.001). Otherwise both groups were
comparable in their pre-transplant parameters. ATN occurred in 71%(GS), interstitial fibrosis/tubular atrophy (IF), arteriolar mediahyper-
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of the NHB and 42% of the HB (p , 0.001). Duration of dialysis rat, it is proposed that the enhanced turnover of this factor may play
a role in the pathogenesis of MCD. The putative predictive value ofdependency was equal. The mean number of days hospitalized were
31.7 and 32.8 (p 5 0.58). Significant risk factors for GS were NHB plasma 100KF in MCD warrants further investigation.
(Odds ratio 1.80, p , 0.02) and age recipient (Odds ratio 1.01, p 5
0.02). The 1 and 5-year overall GS was 68% and 50% for NHB kidneys
versus 80% and 60% in the HB group. Median creatinine clearance Anti-proteinase 3 (PR3) ANCA are better activators of neutrophils
in vitro than anti-myeloperoxidase (MPO) ANCA. C.F.M. Franssen,(ml/min) at 1, 2 and 5 year was 42.3, 38.9 and 49.4 for NHB kidneys
versus 46.7 (p 5 0.28), 45.4 (p 5 0.07) and 46.2 (p 5 0.84) in the HB M.G. Huitema, P.C. Limburg, C.A. Stegeman, C.G.M. Kallenberg, J.W.
Cohen Tervaert. Department of Internal Medicine, University Hospitalgroup. Conclusion: Kidneys from non-heart beating donors are often
disregarded as a potential source of graft. However patients receiving Groningen, The Netherlands. Previously, we found that patients with
anti-PR3 associated active necrotizing crescentic glomerulonephritisthese kidneys reached an acceptable graft survival and function.
(NCGN) had a faster deterioration of renal function and more active
renal lesions than patients with anti-MPO associated NCGN. Since
ANCA-mediated neutrophil activation is thought to play an importantGlomerular visceral epithelial cells (GVEC) express IL-4R2; possible
relevance for GVEC function and minimal change nephrosis (MCN). role in the pathophysiology of this form of glomerulonephritis we
questioned whether anti-PR3 are better activators of neutrophils inJ.G. van den Berg, J. Aten, M.A. Chand, N. Claessen, J.J. Weening.
Department of Pathology, Academic Medical Center, University of Am- vitro than anti-MPO. Therefore, we measured the superoxide produc-
tion by ferricytochrome reduction and the release of granule constit-sterdam, Amsterdam, The Netherlands. The pathogenesis of GVEC
injury in MCN is unknown. An association between the occurrence uents from healthy donor neutrophils upon stimulation with immuno-
globulin (IgG) fractions from 17 anti-PR3 and 14 anti-MPO positiveof MCN and Th2-lymphocyte mediated atopy has been described. To
examine a possible direct role for Th2-type cytokines in damage to patients with active NCGN and IgG fractions from 16 healthy controls.
Patients with anti-PR3 and anti-MPO had comparable serum creatinineGVECs, monolayers of rat GVECs were exposed to IL-4 and IL-13
in a transwell system, in which transepithelial electrical resistance an C-reactive protein levels. Patients with anti-PR3 had a higher renal
activity index compared with patients with anti-MPO (p , 0.05). IgG(TER) was measured, representing monolayer integrity. Both IL-4 and
IL-13 dose-dependently decreased TER, when applied to the basolat- fractions from anti-PR3 positive patients induced more superoxide
release by TNAa-primed neutrophils compared with IgG fractionseral, but not the apical side of the monolayer. Coincubation with TNF-a
did not modify the effects of IL-4 and IL-13. By RT-PCR, cultured from anti-MPO positive patients (p , 0.05) and healthy controls
(p , 0.05). In addition, IgG fractions from anti-PR3 ANCA positivehuman and rat GVECs were shown to express mRNA for both IL-
4Ra and IL-13Ra1 chains, which may form the heterodimeric receptor patients generated more degranulation of b-glucuronidase than IgG
fractions from anti-MPO ANCA positive patients (p , 0.01) andIL-4R2, through which both IL-4 and IL-13 can signal. The common
g chain, which together with IL-4Ra forms the IL-4 specific IL-4R1, healthy controls (p , 0.05). In conclusion, IgG fractions from anti-
PR3 positive patients with NCGN are more potent in inducing thewas not detected in GVECs in vitro. Isolated rat glomeruli expressed
mRNA for IL-4Ra, IL-13Ra1 as well as the common g chain. Finally, respiratory burst and degranulation of neutrophils in vitro than IgG
fractions from anti-MPO positive patients with NCGN. These observa-immunohistochemistry with polyclonal anti-IL-4Ra on human kidney
biopsies revealed predominant staining of GVECs and, to a lesser tions may be relevant in view of the clinical differences between anti-
PR3 and anti-MPO positive patients.extent, of distal tubules and endothelia of large vessels. Staining for
IL-4Ra on GVECs was increased in MCN (n 5 9) in comparison
with other kidney diseases (n 5 29) (p , 0.01), as studied by semi-
quantitative morphometry. In conclusion, IL-4 and IL-13 specifically Human mesangial cells (MC) in culture and in kidney sections fail to
express Fc alpha receptor (CD89). R. Westerhuis, G. van Zandbergen,affect GVEC monolayer integrity in vivo, probably by signaling
through IL-4R2. GVECs in vivo may also express IL-4R2, of which C. van Kooten, N.A.M. Verhagen, N. Klar-Mohamad, M.R. Daha. Dept.
of Nephrology, University Hospital, Leyden, The Netherlands. Thethe expression of the IL-4Ra chain is increased in MCN.
mechanism of deposition of IgA in the renal mesangium in primary
IgA-Nephropathy (IgAN) is poorly understood. It has been suggested
that membrane receptors for IgA on mesangial cells (MC) of the kidneyReduced plasma levels of 100KF in minimal change disease in relapse.
P.K. Cheung, W.H.J. van Luijk*, J. Nauta#, T. Borghuis, W.W. Bakker. may be involved. In order to obtain more insight in the occurrence of
the myeloid receptor for IgA (CD89) on MC, both in situ and inDept. of Pathology and Dept. of Pediatrics*, University Hospital of
Groningen; Sophia Children’s Hospital Rotterdam#, The Netherlands. culture, we raised rabbit- and goat polyclonal antibodies (Ab) and
mouse monoclonal Ab against recombinant CD89. These Ab wereThe mechanisms of increased glomerular permeability in minimal
change disease (MCD) is unknown. A circulating plasma factor with thoroughly characterized and demonstrated to be specific for CD89
expressed on IIA1.6 cells in soluble form and on the surface of thea molecular weight of 80–100 kDa (called 100KF), recently identified
as an isoform of hemopexin, has been associated with MCD. The monocytic cell line U937. Three mm kidney sections from 5 controls
and 5 patients with IgAN were stained with polyclonal and monoclonalpresent study was designed to compare proteinuria in relation with
100KF levels in plasma and urine from subjects with biopsy-proven Abs. Neither controls nor patients showed staining of CD89 in the
renal mesangium. For in vitro studies, primary human MC cultures wereMCD (11 children; age: 4–15 years; 7 males, 4 females) and corticoste-
roid sensitive focal glomerulosclerosis (FSGS) (7 children, age 7–17 established and assessed for CD89 expression. No protein expression of
CD89 on human MCs was detectable in five out of five primary MCyears, 4 males, 3 females). 100KF in plasma samples was assayed
with rabbit-anti-100KF IgG using rocket electrophoresis according to cultures using the various Abs. Furthermore RT-PCR failed to detect
mRNA expression of CD89 in the 5 MCs during passage 3–10. Forstandard techniques. Urinary 100KF was measured using a sandwich
ELISA, and urinary protein by standard pyrogallol method. The results all the above mentioned experiments U937 cells served as a positive
control. It was demonstrated that all 5 human primary MCs boundshow a significantly (P # 0.01) reduced titer of plasma 100KF in all
subjects with MCD in relapse (mean level: 1.81 6 1.29 mg/ml; mean human IgA in a dose-dependent fashion. However the binding of IgA
was not inhibitable by blocking monoclonal anti-CD89 Ab (My43). Inurinary protein: 16.97 6 21.23 mg/ml), versus remission (mean 100KF
level: 3.19 6 1.54 mg/ml; mean urinary protein: 0.37 6 0.50 mg/ml). contrast binding of IgA to U937 cells was dose dependent and was
blocked efficiently by My43. Furthermore, incubation in human MCIn subjects with FSGS no significant alterations in plasma 100KF level
was observed in relapse (mean 100KF titer: 2.50 6 1.55 mg/ml; mean with human and rat IgA both led to activation and subsequent enhance-
ment of Interleukin-6 production by these cells. On the other hand,urinary protein: 8.65 6 11.03 mg/ml), versus remission (mean 100KF
level: 2.16 6 1.93 mg/ml; mean urinary protein: 0.25 6 0.35 mg/ml). using recombinant CD89 and the IIA1.6 CD89 transfected cell line,
we demonstrated that only human IgA but not rat IgA is able to bindAs urinary 100KF is relatively low in all subjects, (ranging from 0.38–
139.10 mg/ml), and not related to the amount of urinary protein in to human CD89. Therefore we conclude that human MC do not express
CD89 to a significant extent. These results strongly suggest that bindingMCD, the reduced plasma level of 100KF in MCD in relapse can not
be explained by urinary loss of 100KF. Since human 100KF is able to of IgA to human mesangial cells occurs via an IgA receptor distinct
from CD89.induce MCD-like glomerular alterations, as well as proteinuria in the
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Polygeline infusion decreases tubular reabsorption of low molecular Forearm blood flow (FBF) was measured by venous occlusion plethys-
mography. Statistical analysis was done using ANOVA for repeatedweight proteins. M.A.G.J. ten Dam, A.J.W. Branten, I. Klasen, J.F.M.
Wetzels. Department of Medicine, University Hospital, Nijmegen, The measures. Results: Infusion with losartan (Los) and AngII showed
significant (p , 0.05) differences in responses of FBF between theNetherlands. Polygelines are widely used as plasma substitutes in order
to maintain circulating volume. In anecdotal reports it has been shown DD and II genotype. The DD genotype having a more pronounced
vasoconstrictor response during AT1 receptor blockade. Infusion withthat infusion of polygelines causes proteinuria. The magnitude and
mechanism of this effect have thusfar not been studied. We have AngII alone showed a trend towards a more pronounced vasoconstric-
tor response (p 5 0.73) in the DD subjects. In the other experimentsinfused 330 ml of polygeline in 6 healthy male subjects at a rate of 8,5
to 16,5 ml/min. Simultaneously an equal amount of blood was with- no significant differences were found. Conclusion: In this in vivo experi-
ment in the human forearm the DD genotype was associated with andrawn in order to maintain volume status. Glomerular filtration rate
(GFR; inulin clearance), effective renal plasma flow (ERPF; PAH up regulation of the AT1 receptor. There was no evidence for increased
conversion of AngI into AngII in this model.clearance), filtration fraction and fractional clearance (FC) of IgG,
albumin (alb), a1-microglobulin (a1-m) and b2-microglobulin (b2m)
were measured one hour before - (B), during - (G), and in the first
(P1) and second hour after polygeline infusion (P2). Results (mean 6 Tolbutamide but not glibenclamide reduces hypoxic damage in the
isolated perfused rat kidney. R. Engbersen, W.M. Moons, C. Kramers,sd) are shown below:
P. Smits, F.G.M. Russel. Department of Pharmacology, University of
Nijmegen, Nijmegen, The Netherlands. Proximal tubules contain an
ATP-dependent potassium channel (K-ATP) which may contribute toB G P1 P2
the often observed loss of intracellular potassium during hypoxia. The
GFR ml/min 127616 128616 121611 113611* K-ATP channel inhibitor glibenclamide (500 microM) has been found
ERPF ml/min 7166185 8396251* 7506202 7486266 to protect against hypoxic damage in isolated rabbit proximal tubules.
FF % 1964 1664* 1764* 1765* We investigated whether such a protection could also be seen in whole-
FCIgG % 3 1029 2686205 7056418** 7676429** 6536356* organ experiments, by using the isolated cell-free perfused rat kidney.
FCalb % 3 1029 99630 137648* 116636 94619 Glibenclamide (100 microM) and tolbutamide (200 microM) were
FCa1m % 0.260.2 1.060.4** 1.260.5** 0.860.4** given 30 minutes before the onset of a 30 minute hypoxic period
FCb2m % 0.0460.02 1864** 2266** 1365** (changing from O2 to N2 gassing of the perfusate) and removed 30
minutes afterwards. The fractional excretion of glucose (FE % gluc)*P , 0.05; ** P , 0.01
and the cumulative excretion of LDH (cLDH) were significantly in-
creased in hypoxic kidneys. Electron microscopy of hypoxic perfused
Conclusion: infusion of polygeline increases excretion of proteins, in kidneys showed severe damage to proximal tubules as compared to
particular those of low molecular weight. This most likely reflects normoxic kidneys. Treatment with tolbutamide significantly reduced
competitive inhibition of tubular protein reabsorption. This effect the FE % gluc and cumulative LDH excretion during hypoxia, whereas
should be considered in studies on patients who have received polyge- glibenclamide significantly increased both parameters.
lines. Polygeline infusion may be a valuable tool to study tubular
handling of proteins.
Normoxia Hypoxia Tolbutamide Glibenclamide
Role of the angiotensin converting enzyme I/D polymorphism in physi- FE % gluc 4.961.6 14.562.3# 5.7 60.4** 21.761.2**
ological responses to angiotensins and bradykinin in the human fore- cLDH mU 224699 18626307# 730 6182* 23946266**
arm vascular system. M.A. van Dijk, I. Kroon, A.H.J. Danser, P.C.
** p , 0.01 or * p , 0.05 for tolbutamide or glibenclamide versus hypoxia,Chang. Leiden University Medical Centre and Erasmus University Rot-
# p , 0.01 fot hypoxia versus normaxia, date expressed as mean 6 SEMterdam. The renin-angiotensin system (RAS) plays an important role
in blood pressure regulation. The angiotensin converting enzyme
(ACE) I/D polymorphism accounts for half the variance of serum These results indicate that 200 microM tolbutamide reduces hypoxic
ACE; the DD genotype associated with the highest serum ACE levels, damage in whole-organ experiments, probably due to an effect on
the II genotype with the lowest. However, a relation with blood pres- proximal tubules. In contrast, 100 microM glibenclamide deteriorated
sure could not be established. Therefore, the effect of the ACE poly- renal functioning after a hypoxic period. Whether the protective effect
morphism may only be present on tissue level. We studied the effect of tolbutamide can be attributed to inhibition of K-ATP channels
of the ACE I/D polymorphism in the human forearm, based on the remains to be elucidated, since tolbutamide may have also inhibited
following hypothesis: 1. Subjects with the DD genotype will have higher chloride-channels at the concentration applied.
conversion of angiotensin I (AngI) into angiotensin II (AngII) and
therefore more pronounced vasoconstrictor responses to AngI infu-
sions and less pronounced vasodilator responses to bradykinin (BK) The effect of uremic ultrafiltrate on the response to calcitriol of
infusions. 2. Subjects with the DD genotype will have higher AngII HL-60 cells. G. Glorieux, R. De Smet, N. Lameire, R. Vanholder.
levels, leading to up- or down regulation of the angiotensin II type I Nephrology Division, University Hospital, Gent Belgium. Chronic renal(AT1) receptor and therefore different vasoconstrictor responses to failure is associated with an abnormal function of the immune systemAng II. Methods: Infusion were given in 8 healthy males with the DD and with a higher risk of malignancy. Calcitriol has been demonstratedand 8 healthy males with the II genotype following the table (infusions to alter some aspects of the immune response; it also causes differentia-1 and 2 are continuous):
tion of malignant cells. It has been demonstrated that uremic serum/
ultrafiltrate inhibits cell-mediated immune response in vitro, and sup-
presses calcitriol synthesis and its biological actions. In the present in
vitro study, we evaluated the effect of uremic ultrafiltrate (UUF) on
the response to 1,25(OH)2D3 of the human promyelocytic leukemiaExp. Infusion I Infusion 2 Infusion 3
cell line, HL-60. The following parameters were evaluated: 1) bromo-
1 SNP — AngI 0.1 AngI 1 AngI 10 deoxyuridine (BrdU) incorporation into the DNA as a parameter of
2 SNP — Meth. 0.2 Meth. 0.6 Meth 2 cell proliferation; 2) luminol-amplified chemiluminescence (CL) re-
3 Saline — BK 0.06 BK 0.6 BK 6 sponse; 3) expression of CD14, a lipopolysaccharide receptor; and 4)
4 Saline — SNP 1 SNP 10 SNP 100 levels of CD14mRNA and VDRmRNA. We found that the ability of
5 Enal 80 SNP AngI 0.5 AngI 5 AngI 50 calcitriol to block cell proliferation (37.4 6 1.9 to 30.5 6 1.9% cells
6 Enal 80 — BK 0.02 BK 0.2 BK 0.02 incorporating BrdU, P , 0.01) was eliminated in the presence of
7 SNP — AngII 0.1 AngII 0.5 AngII 5 calcitriol and UUF (53.40 6 7.53%, P , 0.01 vs. calcitriol); similarly the
8 Los 3000 SNP AngII 0.1 AngII 0.5 AngII 5 CL-response of HL-60 cells was enhanced in the presence of calcitriol
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(20126.2 6 3589.9 to 61528.7 6 8492.7 cpm, P , 0.01), and was sup-
Studies: Baseline ins 50 ins 150pressed again in the presence of calcitriol and UUF (20916.2 6 4269.0
cpm, P , 0.01 vs. calcitriol); finally UUF also inhibited the calcitriol- RPF ml/min SS 434658 18.7%* 115.6%*
induced CD14-expression (71.1 6 3.9 to 54.9 6 6.3% CD14 positive SR 442661 19.9%* 118.3%*
cells, P , 0.05). On the other hand, the calcitriol-induced CD14mRNA CNa/GFR % SS 1.4760.52 237.5%* 249.3%*
levels were not significantly different in the presence of calcitriol and SR 1.3260.67 235.9%* 219.4%
UUF compared to calcitriol alone. This points at an inhibition by UUF FPR % SS 74.815.0 20.1% 22.8%
at post-transcriptional site. Similar data were found for VDRmRNA SR 76.516.9 11.6% 23.5%
levels, although VDRmRNA levels were lower in the presence of FDR % SS 94.012.3 12.6%* 13.7%*
calcitriol (minus 48% of control, P , 0.05) no significant difference SR 94.213.2 11.8%* 11.8%*
was observed in the uremic condition. UUF was fractionated by HPLC * P , 0.05 for the comparison with baseline
and collected from 8 to 16 min (F1), from 17 to 24 min (F2), from 25
to 40 (F3) and from 41 to 60 min (F4). All four fractions blunted the
ability of calcitriol to block cell proliferation (P , 0.05). Compared
to the addition of calcitriol alone, CL-response was suppressed in the effects of insulin in SS and SR hypertensives do not support a role for
presence of F1 and F2, although not significantly. None of the four insulin resistance and hyperinsulinemia in the development of salt
separate fractions significantly inhibited the calcitriol-induced CD14- sensitive hypertension.
expression on HL-60. We conclude that UUF contains factors that
impair calcitriol activated function of HL-60 cells. The differentiation
and immune response of promyelocytic leukemia cells that is induced A sensitive HPLC method for the quantification of free and total
by the supplementation of calcitriol, is neutralized in the presence of p-cresol in patients with chronic renal failure. R. De Smet,1 F. David,1
uremic biological fluids. This may be of relevance for the propensity P. Sandra, N. Lameire, R. Vanholder. Dept. Nephrology, University
to infection and cancer of the uremic patient. Hospital, Gent, Belgium,1 Dept. Organic Chemistry, University, Gent,
Belgium. p-Cresol (p-CR) is a protein bound phenolic compound which
is retained in patients with chronic renal failure (CRF). Several recent
studies suggest that p-CR interferes with various biochemical functions.Insulin’s acute effects on renal sodium handling are similar in salt
In this study a method enabling the determination of total p-CRsensitive and salt resistant hypertensives. J.C. ter Maaten, S.J.L. Bakker,
(bound 1 non-bound) in serum and free p-CR (non-bound) in serumE.H. Serne´, P.M. ter Wee, A.J.M. Donker, R.O.B. Gans. Dept. of Medi-
filtrate is reported. The concentrations and % protein binding (PB)cine, University Hospital Vrije Universiteit, Amsterdam, The Nether-
in serum of healthy controls and in 3 populations of CRF-patients arelands. Salt sensitivity has been associated with insulin resistance. Insulin
compared. The samples are brought at pH 5 3, deproteinized withdecreases renal sodium excretion, but it is not clear whether insulin’s
NaCl and extracted with isopropyl ether. After alkalinization of therenal effects link insulin resistance to salt sensitivity. We assessed the
extract, the organic solvent is evaporised and the dry residue is redis-effects of insulin on glucose uptake, renal hemodynamics and sodium
solved in HCl. The p-CR is analyzed by RP-HPLC on a C18 columnhandling in 10 salt sensitive (SS) and 10 salt resistant (SR) essential
and detected by fluorescence at 284/310 nm as extinction/emissionhypertensives. The change in mean arterial blood pressure on succes-
wavelengths. The procedure is efficient, without interference of othersive high and low sodium diets (10 vs 2 g NaCl/day for 1 wk) amounted
protein bound ligands and/or precursors of p-CR or phenol. By meansto 14 6 3 and 2 6 4 mmHg in SS and SR hypertensives. After a
of spiking experiments, the measurement of the UV-absorbance overbaseline period of 90 min, all subjects underwent a euglycemic clamp the 200–400 nm wavelength range and capillary gas chromatography-
with infusion of two sequential doses of insulin (50 and 150 mU/kg/ mass spectrometry, the considered compound is identified as p-CR.
h) during 90 min periods each. Time-control studies were performed in The detection limit of p-CR is 1.3 mmol/L. Compared to healthy con-
the same subjects. Clearances of 131I-hippuran, 125I-iothalamate, sodium trols (n 5 9), the total serum p-CR levels. Peritoneal Dialyis) patients
and lithium were used to evaluate RPF, CNa/GFR and fractional proxi- (n 5 9), uremic outpatients (n 5 7) and hemodialysis patients (n 5
mal (FPR) and distal (FDR) sodium reabsorption. Insulin-mediated 11), respectively 8.6 6 3.0 versus 62.0 6 19.5, 87.8 6 31.7 and 88.7 6
glucose uptake did not differ between both groups. The table shows 49.3 mmol/L (p , 0.05). The difference is even more important if
the percentual changes during the last 45 min of the clearance periods free p-CR is considered. This corresponds to a decreased PB in CRF
during both insulin infusions (ins 50 and ins 150), compared to baseline patients. It is concluded that the present method allows an accurate
values, and corrected for time-control measurement of both total and free p-CR in serum, and that the
Insulin’s effects on renal sodium handling do not differ between SS measured concentrations in CRF patients are in the range which may
cause biochemical alterations.and SR hypertensives. The similar insulin sensitivity and antinatriuretic
